The International Myeloma Working Group (IMWG) today announced that it has updated the criteria for diagnosing multiple myeloma. A paper outlining the new criteria was published in the journal Lancet Oncology. Multiple myeloma ...
Oct 27, 2014
0
0
A major impediment to treating the deadly brain cancer glioblastoma has been that the most potent chemotherapy can't permeate the blood-brain barrier to reach the aggressive brain tumor.
May 2, 2023
0
103
Using a statistical method developed at St. Jude Children's Research Hospital, investigators found that survivors of pediatric Hodgkin lymphoma not only have more cardiovascular conditions than adults who did not have cancer ...
Jul 25, 2016
0
97
Every kind of cancer can spread to the spine, yet two physician-scientists who treat these patients describe a paucity of guidance for effectively providing care and minimizing pain.
Feb 6, 2018
0
32
Cancer is a disease of our genes - yet our understanding of how our genetic makeup affects our risk of cancer is still rudimentary.
Aug 4, 2016
0
97
Wilmot Cancer Institute patients with advanced melanoma (stage III) now have more options for treatment, thanks to research co-authored by a University of Rochester Medical Center surgical oncologist and published in The ...
Feb 1, 2018
0
12
New data from TERAVOLT, a global consortium that tracks outcomes of people with thoracic cancers affected by COVID-19, offers clues as to why they experienced a high death rate of 33% when the coronavirus swept across Europe.
Jun 16, 2020
0
1
In its first randomized clinical trial, a drug that targets a protein needed by cancer cells to maintain their dogged growth and division has shown considerable promise in combination with chemotherapy in patients with a ...
Jun 15, 2020
0
65
There is a strong connection between breast cancer and the high rate of breast density. These are cases wherein the patient has previously undergone mammography screening and been cleared as 'normal'. A subsequent diagnosis ...
Dec 9, 2016
0
43
Researchers at Radboud university medical center have developed a 'deep learning' system that is better than most pathologists at determining the aggressiveness of prostate cancer. The AI system, which uses tissue samples ...
Jan 9, 2020
0
10
